Tuesday, 26 September 2017 saw the kick-off meeting for CLINNOVA, for which the project partners, as well as stakeholders from politics, industry and research came together for fruitful discussion about various aspects of CLINNOVA.
After an introduction by FNR Secretary General Marc Schiltz, Lydia Mutsch, Luxembourg Minister for Health opened the meeting with a speech touching on the Luxembourgish Government’s diversification strategy, which encompasses the life sciences and healthcare domains, as well as the huge opportunities, especially in the field of digitalisation.
The meeting progressed with Prof Markus Ollert, Director of the Infection and Immunity Department at the Luxembourg Institute of Health, laying out the vision of the CLINNOVA project.
Then it came time for the international partners to present the strengths that have led to their involvement in the CLINNOVA project, beginning with Claus Duedal Pedersen, from the Region of Southern Denmark who spoke about how Denmark’s digital health landscape has evolved and what future challenges are.
The final speech before the afternoon group sessions was delivered by Prof Christof von Kalle from Deutsches Krebsforschungszentrum (DKFZ).
During the afternoon, the stakeholders were split into smaller groups and asked the following questions:
- Where do you see the greatest opportunities?
- What could be ‘showcases’ for Luxembourg?
- What could be potential stumbling blocks?
- Who are the key stakeholders?
After one hour to discuss the key questions, each group presented their findings and the meeting culminated in fruitful discussion about various points raised and discussed during the day.